These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33812156)
1. Design and synthesis of new indole containing biaryl derivatives as potent antiproliferative agents. Yuan S; Feng SQ; Li AQ; Zuo JH; Zhang DQ; Xing YJ; Xie Z; Yu B; Liu HM Bioorg Chem; 2021 May; 110():104821. PubMed ID: 33812156 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach. Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353 [TBL] [Abstract][Full Text] [Related]
3. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules. Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363 [TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5- Yu GX; Hu Y; Zhang WX; Tian XY; Zhang SY; Zhang Y; Yuan S; Song J Molecules; 2022 Aug; 27(15):. PubMed ID: 35956943 [TBL] [Abstract][Full Text] [Related]
6. Novel indole hydrazide derivatives: Synthesis and their antiproliferative activities through inducing apoptosis and DNA damage. Kilic-Kurt Z; Acar C; Ergul M; Bakar-Ates F; Altuntas TG Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000059. PubMed ID: 32419228 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel 2,3-indolinedione derivatives against mantle cell lymphoma. Yu S; Liu Y; Zhang Z; Zhang J; Zhao G Bioorg Med Chem; 2019 Aug; 27(15):3319-3327. PubMed ID: 31229421 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors. OuYang Y; Zou W; Peng L; Yang Z; Tang Q; Chen M; Jia S; Zhang H; Lan Z; Zheng P; Zhu W Eur J Med Chem; 2018 Jun; 154():29-43. PubMed ID: 29775935 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents. Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells. Romagnoli R; Prencipe F; Lopez-Cara LC; Oliva P; Baraldi S; Baraldi PG; Estévez-Sarmiento F; Quintana J; Estévez F J Enzyme Inhib Med Chem; 2018 Dec; 33(1):727-742. PubMed ID: 29620429 [TBL] [Abstract][Full Text] [Related]
11. Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent. He Z; Qiao H; Yang F; Zhou W; Gong Y; Zhang X; Wang H; Zhao B; Ma L; Liu HM; Zhao W Eur J Med Chem; 2019 Dec; 184():111764. PubMed ID: 31614257 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives. Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety. Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells. Shiokawa Z; Hashimoto K; Saito B; Oguro Y; Sumi H; Yabuki M; Yoshimatsu M; Kosugi Y; Debori Y; Morishita N; Dougan DR; Snell GP; Yoshida S; Ishikawa T Bioorg Med Chem; 2013 Dec; 21(24):7938-54. PubMed ID: 24169315 [TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Novel Cytotoxic Indole-Thiosemicarbazone Derivatives: Biological Evaluation and Docking Study. Bakherad Z; Safavi M; Fassihi A; Sadeghi-Aliabadi H; Bakherad M; Rastegar H; Saeedi M; Ghasemi JB; Saghaie L; Mahdavi M Chem Biodivers; 2019 Apr; 16(4):e1800470. PubMed ID: 30845369 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells. He ZX; Huo JL; Gong YP; An Q; Zhang X; Qiao H; Yang FF; Zhang XH; Jiao LM; Liu HM; Ma LY; Zhao W Eur J Med Chem; 2021 Jan; 210():112970. PubMed ID: 33153765 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors. Wang NY; Xu Y; Xiao KJ; Zuo WQ; Zhu YX; Hu R; Wang WL; Shi YJ; Yu LT; Liu ZH Eur J Med Chem; 2020 Apr; 191():112152. PubMed ID: 32088495 [TBL] [Abstract][Full Text] [Related]
18. Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells. Eldehna WM; Abo-Ashour MF; Al-Warhi T; Al-Rashood ST; Alharbi A; Ayyad RR; Al-Khayal K; Abdulla M; Abdel-Aziz HA; Ahmad R; El-Haggar R J Enzyme Inhib Med Chem; 2021 Dec; 36(1):319-328. PubMed ID: 33345633 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]